Details for: RPL10AP6

Gene ID: 100128936

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL10AP6

Ensembl ID: ENSG00000226360

Description: ribosomal protein L10a pseudogene 6

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 19.85
    rCSI 15.9%
    PRS 98.54
  • endocrine cell CL0000163
    CSI 9.21
    rCSI 47.24%
    PRS 99.65
  • professional antigen presenting cell CL0000145
    CSI 8.23
    rCSI 28.35%
    PRS 99.01
  • retinal cone cell CL0000573
    CSI 7.43
    rCSI 11.96%
    PRS 99.57
  • primordial germ cell CL0000670
    CSI 5.72
    rCSI 28.59%
    PRS 98.49

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL10AP6](/details-gene/100128936) is a pseudogene located on chromosome 3p14.2 in *Homo sapiens*. It is identified as a non-protein-coding gene derived from the ribosomal protein L10a. Despite being a pseudogene, its expression pattern suggests potential regulatory functions. **Overall**, its transcript shows exceptionally high significance in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810), indicating a potential role in T cell development. It is also significantly expressed, albeit to a lesser extent, in a diverse range of other cell types, including [endocrine cells](/details-cell/CL0000163), [professional antigen presenting cells](/details-cell/CL0000145), and [retinal cone cells](/details-cell/CL0000573), which may point towards a role in fundamental processes within highly specialized cells. ## Cellular Roles and Expression Landscape The expression profile of [RPL10AP6](/details-gene/100128936) is defined by its remarkably high Cell Significance Index (CSI) of 19.85 in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810). This strong and specific association suggests that [RPL10AP6](/details-gene/100128936) may serve as a marker for this stage of T cell maturation or play an active regulatory role during thymic development. Beyond this primary cell type, the gene exhibits moderate significance in other immunologically relevant cells, such as [professional antigen presenting cells](/details-cell/CL0000145). Its expression extends to functionally disparate and highly specialized cell populations, including [endocrine cells](/details-cell/CL0000163), which are responsible for hormone synthesis, [retinal cone cells](/details-cell/CL0000573), which are critical for vision, and [primordial germ cells](/details-cell/CL0000670), the precursors to gametes. This broad but selective expression pattern in functionally demanding cells might suggest its involvement in regulating core cellular machinery, such as protein synthesis, a function directly related to its parent gene. ## Pathways and Molecular Function Direct functional annotation for [RPL10AP6](/details-gene/100128936) is not available, which is common for pseudogenes. However, its origin from the ribosomal protein L10a gene implies a potential connection to the regulation of ribosome biogenesis and protein translation. Expressed pseudogenes can function as competitive endogenous RNAs (ceRNAs), sequestering microRNAs and thereby influencing the expression levels of their parent gene and other related transcripts. In the context of rapidly proliferating and differentiating cells like [thymocytes](/details-cell/CL0000810), precise control over protein synthesis is critical, and [RPL10AP6](/details-gene/100128936) might contribute to this regulatory network. ## Research Directions The unique expression profile of [RPL10AP6](/details-gene/100128936), particularly its specificity for [thymocytes](/details-cell/CL0000810), presents several avenues for future research. **Proposed Hypotheses:** 1. The highly specific expression of [RPL10AP6](/details-gene/100128936) in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) indicates it functions as a ceRNA to fine-tune the expression of its parent gene, RPL10A, a critical factor for ribosome production during T cell receptor repertoire selection and thymocyte proliferation. 2. Dysregulation of [RPL10AP6](/details-gene/100128936) expression contributes to developmental blocks or malignant transformation in T-cell lineages, such as T-cell acute lymphoblastic leukemia (T-ALL), which originates from thymocyte precursors. **Suggested Experimental Approach:** To test the hypothesis that [RPL10AP6](/details-gene/100128936) regulates thymocyte development, one could utilize CRISPR-Cas9 to knock out the gene in a human T-cell progenitor cell line or primary hematopoietic stem cells. These modified cells could then be differentiated *in vitro* towards the T-cell lineage. The developmental progression could be monitored using flow cytometry for stage-specific markers (e.g., CD4, CD8). Parallel transcriptomic analysis (RNA-seq) would reveal the impact of the knockout on the expression of RPL10A and other genes involved in ribosome biogenesis and T-cell signaling pathways. **Therapeutic Potential:** As a non-coding RNA, [RPL10AP6](/details-gene/100128936) is not a target for conventional small-molecule inhibitors. However, its high specificity for [thymocytes](/details-cell/CL0000810) makes it an attractive candidate for RNA-based therapeutics. If its overexpression is linked to T-cell malignancies, antisense oligonucleotides (ASOs) or siRNAs could be designed to specifically degrade the [RPL10AP6](/details-gene/100128936) transcript. Such an approach would represent a targeted therapy with a potentially high therapeutic window, minimizing off-target effects on other tissues. Therefore, inhibition of its function or expression would be the likely therapeutic strategy.